Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials von Griffiths, Christopher E M, Prof, Reich, Kristian, Prof, Lebwohl, Mark, Prof, van de Kerkhof, Peter, Prof, Paul, Carle, Prof, Menter, Alan, MD, Cameron, Gregory S, PhD, Erickson, Janelle, PhD, Zhang, Lu, MS, Secrest, Roberta J, PhD, Ball, Susan, PhD, Braun, Daniel K, MD, Osuntokun, Olawale O, MD, Heffernan, Michael P, MD, Nickoloff, Brian J, MD, Papp, Kim, MD

Volltext

Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from... von Saeki, Hidehisa, Nakagawa, Hidemi, Nakajo, Ko, Ishii, Taeko, Morisaki, Yoji, Aoki, Takehiro, Cameron, Gregory S., Osuntokun, Olawale O., Akasaka, Toshihide, Asano, Yoshihide, Etoh, Takafumi, Fujita, Yasuyuki, Hashimoto, Takashi, Higashiyama, Mari, Igarashi, Atsuyuki, Ihn, Hironobu, Iwatsuki, Keiji, Kabashima, Kenji, Kawada, Akira, Kawashima, Makoto, Nakamura, Koichiro, Okubo, Yukari, Okuyama, Ryuhei, Ozawa, Akira, Sayama, Koji, Seishima, Mariko, Shiohara, Tetsuo, Takahara, Masakazu, Takahashi, Hidetoshi, Takehara, Kazuhiko, Tanese, Keiji, Tani, Mamori, Umezawa, Yoshinori, Watanabe, Hideaki, Yamanaka, Keiichi

Volltext

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis von Gordon, Kenneth B, Blauvelt, Andrew, Papp, Kim A, Langley, Richard G, Luger, Thomas, Ohtsuki, Mamitaro, Reich, Kristian, Amato, David, Ball, Susan G, Braun, Daniel K, Cameron, Gregory S, Erickson, Janelle, Konrad, Robert J, Muram, Talia M, Nickoloff, Brian J, Osuntokun, Olawale O, Secrest, Roberta J, Zhao, Fangyi, Mallbris, Lotus, Leonardi, Craig L

Volltext

A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia von KINON, Bruce J, LU ZHANG, MILLEN, Brian A, OSUNTOKUN, Olawale O, WILLIAMS, Judy E, KOLLACK-WALKER, Sara, JACKSON, Kimberley, KRYZHANOVSKAYA, Ludmila, JARKOVA, Natalia

Volltext

Factors associated with adherence to treatment with olanzapine and other atypical antipsychotic medications in patients with schizophrenia von Liu-Seifert, Hong, Osuntokun, Olawale O, Feldman, Peter D

Volltext

Patient perspectives on antipsychotic treatments and their association with clinical outcomes von Liu-Seifert, Hong, Osuntokun, Olawale O, Godfrey, Jenna L, Feldman, Peter D

Volltext

LY2140023 MONOHYDRATE: AN AGONIST AT THE MGLU2/3 RECEPTOR FOR THE TREATMENT OF SCHIZOPHRENIA von Kinon, Bruce J, Zhang, Lu, Williams, Judy E, Osuntokun, Olawale O, Millen, Brian A, Kollack-Walker, Sara

Volltext